Brainstem changes in 5-HT1A receptor availability during migraine attack

Cephalalgia

Volumn 31, Issue 1, 2011, Pages 84-94

  Demarquay, G ^a,b   Lothe, A ^b,c,d   Royet, J P ^b,c   Costes, N ^b,c   Mick, G ^e   Mauguiere F ^b,e   Ryvlin, P ^b,c,d,e  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Centre d'Explorations et de Recherches Médicales Par Emission de Positons   (France)

^d INSERM   (France)

^e Hopital Neurologique   (France)

Author keywords

5HT1A receptors; Migraine; olfactory hypersensitivity; PET; serotonin

Indexed keywords

2' METHOXYPHENYL(N 2' PYRIDINYL) 4 FLUORO BENZAMIDOETHYLPIPERAZINE F 18; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BRAIN MAPPING; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MESENCEPHALIC RAPHE NUCLEUS; MIGRAINE; ODOR; OLFACTORY STIMULUS; ORBITAL CORTEX; PONTINE RAPHE NUCLEUS; POSITRON EMISSION TOMOGRAPHY; PRIMARY MOTOR CORTEX; PROTEIN LOCALIZATION; RAPHE NUCLEUS; RECEPTOR OCCUPANCY; SENSORY STIMULATION; TEMPORAL LOBE;

EID: 79751488164     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410385581     Document Type: Article

References (50)

1. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia 2007 ; 27: 1293-1300.
2. Ferrari MD, Odink J., Tapparelli C., Van Kempen GM, Pennings EJ and Bruyn GW Serotonin metabolism in migraine. Neurology 1989 ; 39: 1239-1242. (Pubitemid 19239731)
3. Wang W., Timsit-Berthier M. and Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission? Neurology 1996 ; 46: 1404-1409. (Pubitemid 26159305)
4. Coppola G., Pierelli F. and Schoenen J. Habituation and migraine. Neurobiol Learn Mem 2009 ; 92: 249-259.
5. Schuh-Hofer S., Richter M., Geworski L., et al. Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol 2007 ; 254: 789-796. (Pubitemid 47012461)
6. Weiller C., May A., Limmroth V., et al. Brainstem activation in spontaneous human migraine attacks. Nat Med 1995 ; 1: 568-660.
7. Bahra A., Matharu MS, Buchel C., Frackowiak RSJ and Goadsby PJ Brainstem activation specific to migraine headache. Lancet 2001 ; 357: 1016-1017. (Pubitemid 32285399)
8. Afridi SK, Matharu MS, Lee L., et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005 ; 128: 932-939. (Pubitemid 40516929)
9. Afridi SK, Giffin NJ, Kaube H., et al. A PET study in spontaneous migraine. Arch Neurol 2005 ; 62: 1270-1275.
10. Denuelle M., Fabre N., Payoux P., Chollet F. and Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007 ; 47: 1418-1426. (Pubitemid 350209521)
11. Sakai Y., Dobson C., Diksic M., Aubé M. and Hamel E. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 2008 ; 70: 431-439.
12. Weissmann-Nanopoulos D., Mach E., Magre S., Demassay Y. and Pujol JF Evidence for the localization of 5HT1-A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 1985 ; 7: 1061-1072. (Pubitemid 16185105)
13. Richer M., Hen R. and Blier P. Modification of serotonin neuron properties in mice lacking 5-HT1A receptors. Eur J Pharmacol 2002 ; 435: 195-203. (Pubitemid 34131700)
14. Leone M., Attanasio A., Croci D., et al. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. Neuroreport 1998 ; 9: 2605-2608. (Pubitemid 28387157)
15. Cassidy EM, Tomkins E., Dinan T., Hardiman O. and O'Keane V. Central 5-HT receptor hypersensitivity in migraine without aura. Cephalalgia 2003 ; 23: 29-34. (Pubitemid 36356801)
16. Cassidy EM, Tomkins E., Sharifi N., Dinan T., Hardiman O. and O'Keane V. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Pain 2003 ; 101: 283-290. (Pubitemid 36175521)
17. Lothe A., Merlet I., Demarquay G., Costes N., Ryvlin P. and Mauguière F. Interictal Brain 5-HT1A receptors binding in migraine without aura: a MPPF PET study. Cephalalgia 2008 ; 28: 1282-1291.
18. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. 2nd edn. Cephalalgia 2004 ; 24: 9-160.
19. Szarek MJ, Bell IR and Schwartz GE Validation of a brief screening measure of environmental chemical sensitivity: the chemical odor intolerance index. J Environmental Psychology 1997 ; 17: 345-351. (Pubitemid 127170243)
20. Demarquay G., Royet JP, Mick G. and Ryvlin P. Olfactory hypersensitivity in migraineurs: a H215O-PET study. Cephalalgia 2008 ; 28: 1069-1080.
21. Plenevaux A., Lemaire C., Aerts J., et al. [(18)F]p-MPPF: A radiolabeled antagonist for the study of 5-HT(1A) receptors with PET. Nucl Med Biol 2000 ; 27: 467-471. (Pubitemid 30658148)
22. Zimmer L., Mauger G., Le Bars D., Bonmarchand G., Luxen A. and Pujol JF Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J Neurochem 2002 ; 80: 278-286. (Pubitemid 34809373)
23. Rbah L., Leviel V. and Zimmer L. Displacement of the PET ligand 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus. Synapse 2003 ; 49: 239-245. (Pubitemid 36927965)
24. Le Bars D., Lemaire C., Ginovart N., et al. High-yield radiosynthesis and preliminary in vivo evaluation of [18F]MPPF, a fluroro analog of WAY-100635. Nucl Med Biol 1998 ; 25: 343-350. (Pubitemid 28219097)
25. Gunn RN, Sargent PA, Bench CJ, et al. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl11C]WAY-100635 for PET. Neuroimage 1998 ; 8: 426-440. (Pubitemid 28545940)
26. Costes N., Merlet I., Ostrowsky K., et al. A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med 2005 ; 46: 1980-1989. (Pubitemid 46657443)
27. Mazziotta J., Toga A., Evans A., et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 2001 ; 356: 1293-1322. (Pubitemid 32876067)
28. Friston KJ, Holmes A., Poline JB, Price CJ and Frith CD Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 1996 ; 4: 223-235.
29. Hornung JP The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003 ; 26: 331-343.
30. Kaube H., Keay KA, Hoskin KL, Bandler R. and Goadsby PJ Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 1993 ; 629: 95-102.
31. Knight YE and Goadsby PJ The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 2001 ; 106: 793-800. (Pubitemid 33000183)
32. Knight YE, Classey JD, Lasalandra MP, et al. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Brain Res 2005 ; 1045: 1-11. (Pubitemid 40725214)
33. Lambert GA, Hoskin KL and Zagami AS Cortico-NRM influences on trigeminal neuronal sensation. Cephalalgia 2008 ; 28: 640-652. (Pubitemid 351614941)
34. Katsarava Z., Egelhof T., Kaube H., Diener HC and Limmroth V. Symptomatic migraine and sensitization of trigeminal nociception associated with contralateral pontine cavernoma. Pain 2003 ; 105: 381-384. (Pubitemid 37162509)
35. Frey BN, Rosa-Neto P., Lubarsky S. and Diksic M. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study. Neuroimage 2008 ; 42: 850-857.
36. Drummond PD Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology 2005 ; 65: 620-622. (Pubitemid 41170729)
37. Drummond PD Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia 2006 ; 26: 1225-1233. (Pubitemid 44359345)
38. Supornsilpchai W., Sanguanrangsirikul S., Maneesri S. and Srikiatkhachorn A. Serotonin depletion, cortical spreading depression, and trigeminal nociception. Headache 2006 ; 46: 34-39.
39. Invernizzi R., Carli M., Di Clemente A. and Samanin R. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: differences in potency and regional sensitivity. J Neurochem 1991 ; 56: 243-247. (Pubitemid 21901955)
40. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000 ; 20: 423-451. (Pubitemid 30164887)
41. Mamounas LA and Molliver ME Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Exp Neurol 1988 ; 102: 23-36.
42. Wilson MA and Molliver ME The organization of serotonergic projections to cerebral cortex in primates: regional distribution of axon terminals. Neuroscience 1991 ; 44: 537-553.
43. Hall SD, Barnes GR, Hillebrand A., Furlong PL, Singh KD and Holliday IE Spatio-temporal imaging of cortical desynchronization in migraine visual aura: a magnetoencephalography case study. Headache 2004 ; 44: 204-208. (Pubitemid 38436681)
44. Royet JP, Zald D., Versace R., et al. Emotional responses to pleasant and unpleasant olfactory, visual, and auditory stimuli: a positron emission tomography study. J Neurosci 2000 ; 20: 7752-7759.
45. Gottfried JA, O'Doherty J. and Dolan RJ Appetitive and aversive olfactory learning in humans studied using event-related functional magnetic resonance imaging. J Neurosci 2002 ; 22: 10829-10837. (Pubitemid 36005157)
46. Peyron R., Laurent B. and Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 2000 ; 30: 263-288.
47. Frot M., Magnin M., Mauguière F. and Garcia-Larrea L. Human SII and posterior insula differently encode thermal laser stimuli. Cereb Cortex 2007 ; 17: 610-620.
48. Royet JP and Plailly J. Lateralization of olfactory processes. Chem Senses 2004 ; 29: 731-745. (Pubitemid 41289294)
49. Rolls ET Convergence of sensory systems in the orbitofrontal cortex in primates and brain design for emotion. Anat Rec A Discov Mol Cell Evol Biol 2004 ; 281: 1212-1225. (Pubitemid 39458665)
50. García-Larrea L., Peyron R., Mertens P., et al. Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 1999 ; 83: 259-273. (Pubitemid 29479285)